BAL PHARMA
Back to Balance Sheet
|
BAL PHARMA Last 5 Year Total Non-Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Non-Current Liabilities | ₹38 Cr | ₹45 Cr | ₹38 Cr | ₹36 Cr | ₹34 Cr |
What is the latest Total Non-Current Liabilities ratio of BAL PHARMA ?
| Year | Total Non-Current Liabilities |
|---|---|
| Mar2025 | ₹38 Cr |
| Mar2024 | ₹45 Cr |
| Mar2023 | ₹38 Cr |
| Mar2022 | ₹36 Cr |
| Mar2021 | ₹34 Cr |
How is Total Non-Current Liabilities of BAL PHARMA Trending?
| Years | Total Non-Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹38 Cr | -14.36 | |
| Mar2024 | ₹45 Cr | 18.02 | |
| Mar2023 | ₹38 Cr | 4.32 | |
| Mar2022 | ₹36 Cr | 6.44 | |
| Mar2021 | ₹34 Cr | - | |
Compare Total Non-Current Liabilities of peers of BAL PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| BAL PHARMA | ₹124.7 Cr | 0.5% | 16.1% | -26.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹403,052.0 Cr | 0.3% | -3.7% | -4.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹169,336.0 Cr | 2.4% | 6.7% | 11.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹140,311.0 Cr | -0.8% | -1.5% | 25.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹111,264.0 Cr | 7.9% | 4.6% | 4.6% | Stock Analytics | |
| CIPLA | ₹105,484.0 Cr | 5.5% | 5.4% | -18.5% | Stock Analytics | |
BAL PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| BAL PHARMA | 0.5% |
16.1% |
-26.6% |
| SENSEX | -0.4% |
1.3% |
0.8% |
You may also like the below Video Courses